Page 25 - Vaccine

Unascertained side effects of a vaccine and the lack of damages law

While the mechanism for compensating people who have had AEFI during a clinical trial is present, there is no such formal system for compensation when a vaccine is in the market.

Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Talks are also on with five major Indian manufacturers here to produce the vaccine for India and the world

US plans 'marathon campaign' to give free Covid-19 vaccine to citizens

The Pentagon is involved with the distribution of vaccines, but civilian health workers will be the ones giving shots

World Coronavirus Dispatch: EU states to pilot Covid-tracing apps

Israel going back to lockdown, UK sets new cap on social gatherings, Refugee camp in Greece burned to the ground and other pandemic-related news across the globe

India may have crossed 6.4 mn cases in May, ahead of US: Serosurvey

ICMR report found seroprevalence in the 0.62-1.03% range across four strata of districts, from zero to high level of cases; 30,283 households were visited in 700 clusters across 70 districts

World Coronavirus Dispatch: Is South Africa becoming a failed state?

China's vaccine frontrunner says its shots are safe, Canada flight cancelled over child without mask, Auto stocks bounce back in Europe and other pandemic-related news across the globe

What Serum Institute's persistence on Oxford vaccine trials means for India

The company is going ahead regardless of AsraZeneca pausing trials in UK after an adverse impact was reported

BCG vaccine protects old people from respiratory infections: Report

BCG vaccine, originally made against TB, is effective against various infections -- possibly also Covid-19, say researchers, adding that it also protects elderly people from respiratory infections

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

New antibody tests offer a better snapshot of coronavirus immunity

Quantitative antibody testing could also help with treatments involving convalescent plasma

Russia likely to start Covid-19 mass vaccination from January 1, 2021

Teachers and medical workers will be the first to get the Covid-19 vaccine jointly developed by the Gamaleya Research Institute and the Russian Defence Ministry

We are looking at vaccines as new growth pivot: Strides Pharma chief

In a Q&A, pharma major's MD & CEO, R Ananthanarayanan says the firm is setting up a vaccine suite and is in final-stage talks with global players to seal a deal for developing a Covid-19 vaccine

Large-scale US Covid-19 vaccine trials will exclude pregnant women for now

Drugmakers say they first need to make sure the vaccines are safe and effective more generally

GSK profit misses as vaccine sales disappoint, stockpiling eases

The company said it still expects adjusted earnings per share for the year to decline in the range of 1% to 4%

Why vaccines can't be launched overnight

Under normal circumstances, the development of new vaccines and treatments could take 10-20 years

India's 1st indigenously developed vaccine against pneumonia gets DCGI nod

The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India

Lakshmi Mittal gifts GBP 3.5 mn to Oxford for developing Covid-19 vaccine

Lakshmi Mittal said, "This year has been a wake-up call to the world to be better prepared for pandemics, which, as we have all experienced, can cause massive social and economic disruption."

UK begins trial of latest virus vaccine this week with 300 candidates

The British government said 300 healthy people will be immunized with two doses of the Covid-19 vaccine candidate developed at Imperial, which has been backed by 41 million pounds

AstraZeneca agrees to supply Europe with 400 mn doses of Covid-19 vaccine

The deal is the latest by AstraZeneca to pledge supply of its vaccine to governments who have scrambled to agree advance purchases of promising coronavirus vaccines

WHO calls for more research on asymptomatic transmission of Covid-19

Saying that the world has been achieving a lot in knowing the new virus, the WHO chief told reporters that "there's still a lot we don't know"